Fig. 4From: Transcription factor LHX9 (LIM Homeobox 9) enhances pyruvate kinase PKM2 activity to induce glycolytic metabolic reprogramming in cancer stem cells, promoting gastric cancer progressionEffect of knockdown of LHX9 on the reprogramming of glycolytic metabolism and malignant biological properties of GCSCs. A: RT-qPCR and Western Blot to detect the effect of knockdown of LHX9 on PKM2 activity in GCSCs; B: changes in lactate levels in GCSCs after knockdown of LHX9; C: changes in ATP expression in GCSCs after knockdown of LHX9; D: RT-qPCR and Western Blot to detect the effect of knockdown of LHX9 on GCSCs transcriptional activity and protein expression changes of glycolysis-related genes (GLUT1, HK2, LDHA, and PDK1) in GCSCs after knockdown of LHX9; E–F: CCK-8 and EDU assays to detect the effect of knockdown of LHX9 on the proliferation ability of GCSCs; G-H: Transwell and scratch assays to detect the effect of knockdown of LHX9 on the migration and invasion ability of GCSCs; NC: Human normal gastric epithelial cells (GSE-1); sh-NC: GCSCs transfected with sh-NC by lentivirus; sh-LHX9: GCSCs transfected with knockdown LHX9 by lentivirus; *: P < 0.05, statistically significant comparison between groups; Data comparison between the two groups was conducted using an independent samples t-test. For different time points, a two-factor analysis of variance (ANOVA) was employed to analyze the cellular data. The cell experiments were repeated three timesBack to article page